Abstract
Nausea and emesis can occur for multiple reasons. While research staff can readily empathize with this type of discomfort, proper assessment and treatment can be challenging. In order to provide optimal care for canine research subjects, it is critical that institutions develop a treatment plan and take preemptive measures to control nausea and emesis when they occur.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Elwood, C. et al. Emesis in dogs: a review. J. Small Anim. Pract. 51, 4–22 (2010).
Ramsey, D. et al. Cerenia prevents perioperative nausea and vomiting and improves recovery in dogs undergoing routine surgery. Intern. J. Appl. Res. Vet. Med. 12, 228–237 (2014).
Peeters, M.E. & Kirpensteijn, J. Comparison of surgical variables and short-term postoperative complications in healthy dogs undergoing ovariohysterectomy or ovariectomy. J. Am. Vet. Med. Assoc. 238, 189–194 (2011).
Murrell, J.C., Psatha, E.P., Scott, E.M., Reid, J. & Hellebrekers, L.J. Application of a modified form of the Glasgow pain scale in a veterinary teaching centre in the Netherlands. Vet. Rec. 162, 403–408 (2008).
Morton, C.M., Reid, J., Scott, E.M., Holton, L.L. & Nolan, A.M. Application of a scaling model to establish and validate an interval level pain scale for assessment of acute pain in dogs. Am. J. Vet. Res. 66, 2154–2166 (2005).
Carpenter, R.E., Wilson, D.V. & Evans, A.T. Evaluation of intraperitoneal and incisional lidocaine or bupivacaine for analgesia following ovariohysterectomy in the dog. Vet. Anaesth. Analg. 31, 46–52 (2004).
Norred, C.L. Antiemetic prophylaxis; pharmacology and therapeutics. AANA J. 71, 133–141 (2003).
Ramsey D.S. et al. Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs. J. Vet. Pharmacol. Ther. 31, 538–543 (2008).
Conder, G.A., Sedlacek, H.S., Boucher, J.F. & Clemence, R.G. Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs. J. Vet. Pharmacol. Ther. 31, 528–532 (2008).
Benchaoui, H.A. et al. Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs. Vet Rec. 161, 444–447 (2007).
de la Puente-Redondo, V.A. et al. The antiemetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe. J. Small. Anim. Pract. 48, 93–98 (2007).
US Food and Drug Administration. Original New Animal Drug Application: Cerenia. (US Food and Drug Administration, Silver Spring, MD, 2007) http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrug Products/FOIADrugSummaries/UCM050060.pdf
Plumb, D.C. Plumb Veterinary Drug Handbook. 8th ed. (Wiley-Blackwell, Ames, 2008).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hampshire, V. Altered states part 2: addressing nausea in canine research subjects. Lab Anim 45, 61–62 (2016). https://doi.org/10.1038/laban.931
Published:
Issue Date:
DOI: https://doi.org/10.1038/laban.931
